Table 5.
Sedation-related adverse events during and immediately after endoscopic retrograde cholangiopancreatography (n, %)
| Group Ca (n = 52) | Group Nb (n = 48) | P value | |
|---|---|---|---|
| Overall | 32 (61.5) | 19 (39.6) | 0.028* |
| Cardiovascular | 24 (46.2) | 17 (35.4) | 0.275 |
| Hypotension | 20 (38.5) | 14 (29.2) | 0.327 |
| Hypertension | 1 (1.9) | 0 | 0.334 |
| Bradycardia | 2 (3.8) | 1 (2.1) | 0.606 |
| Tachycardia | 0 | 2 (4.2) | 0.137 |
| Arrhythmia | 1 (1.9) | 0 | 0.334 |
| Respiratory | 8 (15.4) | 2 (4.2) | 0.062 |
| Hypoxia (oxygen saturation <95%) | 4 (7.7) | 1 (2.1) | 0.199 |
| Upper airway obstruction | 4 (7.7) | 1 (2.1) | 0.199 |
Notes:
a
Group C: clinical assessment;
b
Group N: NarcotrendTM monitoring;
*
Considered to be of statistical significance.